Trial Profile

A clinical study of covid-19 vaccine in combination with oral adjuvant 7HP-349 for older adults

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 25 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Alintegmod (Primary) ; COVID-19 Vaccine 7 Hills Pharma (Primary)
Indications COVID 2019 infections
Focus Adverse reactions
Sponsors 7 Hills Pharma

Most Recent Events

09 Nov 2020 According to a 7 Hills Pharma media release, the company expect to move into this trial in 2021.
04 Aug 2020 According to a 7 Hills Pharma media release, the company expects to initiate this trial in the Fall of 2020.
21 Apr 2020 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com